Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
13.63
+4.07 (42.57%)
At close: May 15, 2026, 4:00 PM EDT
13.90
+0.27 (1.98%)
Pre-market: May 18, 2026, 6:41 AM EDT

Ernexa Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
15.89M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024582.00K514.00K755.88%
Dec 31, 202368.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 201224.06M194.00K0.81%
Dec 31, 201123.87M-1.44M-5.69%
Dec 31, 201025.31M-505.00K-1.96%
Dec 31, 200925.81M-1.68M-6.12%
Dec 31, 200827.50M-3.05M-9.97%
Dec 31, 200730.54M-2.44M-7.41%
Dec 31, 200632.99M2.24M7.27%
Dec 31, 200530.75M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Lipocine2.00M
SeaStar Medical Holding1.44M
CytoMed Therapeutics669.28K
Exicure500.00K
Lexaria Bioscience368.00K
Cocrystal Pharma225.00K
Revenue Rankings